UBC in the News: Experts Take On Real-World Evidence

Exploring industry changes leading to the focus on real-world evidence

UBC in the News: Experts Take On Real-World Evidence

While the term is nothing new, the focus on the topic of real-world evidence is suddenly reaching a fever pitch, and that’s understandable. Demands from payers, patients, prescribers, and regulators for definitive data have never been greater.

Clinical Leader invited UBC’s Haley Kaplowitz, Ph.D., Executive Director, Safety, Epidemiology, Registries, and Risk Management, along with three other industry experts, to participate in a Q&A series exploring the industry changes leading to the focus on real-world evidence.

An epidemiologist with more than 20 years of experience in healthcare,  Haley is an expert in risk management, designing and implementing disease and product registries to meet regulatory requirements and address commercial objectives while examining real-world use of drugs and associated outcomes.

Don’t miss Haley’s insights in Clinical Leader’s Q&A.

Part 1: Why You Should Care About Real-World Evidence (A Lot)

Part 2: Real-World Evidence & The 21st Century Cures Act - What You Need to Know

Part 3: How Interested Is The FDA In Real-World Evidence?